The global Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$10,191.4 million in 2020 and is expected to exhibit a CAGR of 7.3% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
The Saudi Arabia pharmaceutical drugs for market refers to the market for pharmaceutical drugs in Saudi Arabia. The market includes prescription drugs, over-the-counter drugs, and generic drugs. The rising healthcare expenditure and the growing geriatric population are driving the demand for pharmaceutical drugs in Saudi Arabia. The market offers a wide range of drugs for various medical conditions, including cardiovascular diseases, diabetes, respiratory diseases, cancer, and infectious diseases.
B) Market Dynamics:
The Saudi Arabia pharmaceutical drugs for market is primarily driven by two key factors. Firstly, the increasing healthcare expenditure in the country is fueling the demand for pharmaceutical drugs. Saudi Arabia has been investing significantly in its healthcare infrastructure and is focusing on providing quality healthcare services to its citizens. This has led to a rise in the demand for pharmaceutical drugs.
Secondly, the growing geriatric population in Saudi Arabia is also contributing to the growth of the pharmaceutical drugs market. As the population ages, the incidence of chronic diseases and conditions increases, leading to a higher demand for pharmaceutical drugs. The elderly population requires continuous medication for various diseases and disorders, creating a steady demand in the market.
For example, the prevalence of diabetes is increasing among the Saudi Arabian population, especially among the elderly. As a result, there is a growing need for diabetic medications such as insulin and oral hypoglycemic agents.
C) Market Key Trends:
One key trend in the Saudi Arabia Pharmaceutical Drugs Market is the increasing adoption of telemedicine. Telemedicine allows patients to consult with healthcare professionals remotely, reducing the need for in-person visits to hospitals or clinics. This trend has gained momentum during the COVID-19 pandemic when physical distancing measures were implemented to reduce the spread of the virus. Telemedicine provides a convenient and efficient way for patients to access medical advice and prescriptions without leaving their homes.
For example, clinics and pharmacies in Saudi Arabia have started offering teleconsultation services, allowing patients to receive prescriptions for their required medications through virtual appointments. This trend is expected to continue even after the pandemic as it offers convenience and accessibility to patients, especially those living in remote areas.
D) SWOT Analysis:
Strengths:
1. Increasing healthcare expenditure
2. Growing geriatric population
Weaknesses:
1. Dependencies on imports for pharmaceutical drugs
2. Limited availability of certain specialized drugs
Opportunities:
1. Investment in research and development for innovative drugs
2. Expansion of healthcare infrastructure
Threats:
1. Competition from generic drug manufacturers
2. Stringent regulations for drug approvals
E) Key Takeaways:
Ø The Saudi Arabia Pharmaceutical Drugs Market is expected to witness high growth, exhibiting a CAGR of 7.3% over the forecast period, due to increasing healthcare expenditure and the growing geriatric population. The market offers a wide range of drugs for various medical conditions.
Ø In terms of regional analysis, Saudi Arabia is expected to be the fastest-growing and dominating region in the pharmaceutical drugs market in the Middle East. The country's efforts to enhance its healthcare infrastructure, along with the rising demand for quality healthcare services, are driving the market growth.
Ø Key players operating in the Saudi Arabia pharmaceutical drugs for market include Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., AstraZeneca Plc, Baxter International Inc., Life Care Group of Pharmacies, Tadawi Pharmacies, Planet Pharmacies (Zahrat Al Rawdah), Al-Safwwa Pharmacy, Al Nahdi Medical, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Tabuk Pharmaceuticals, Hikma Pharmaceuticals PLC, Jamjoom Pharmaceuticals Co., and Julphar. These companies play a crucial role in fulfilling the demand for pharmaceutical drugs in the Saudi Arabian market and are focused on expanding their product portfolios and enhancing their market presence.
